Search Results - "Kloke, Otto" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial

by Hüttmann, Andreas, Müller, Stefan P, Rekowski, Jan, Hertenstein, Bernd, Franzius, Christiane, Franzke, Anke, Bengel, Frank M, Kroschinsky, Frank, Kotzerke, Jörg, La Rosée, Paul, Freesmeyer, Martin, Hoeffkes, Heinz-Gert, Hertel, Andreas, Behringer, Dirk, Mesters, Rolf, Weckesser, Matthias, Mahlmann, Stefan, Haberkorn, Uwe, Martens, Uwe, Prange-Krex, Gabriele, Korfel, Agnieszka, Brenner, Winfried, Giagounidis, Aristoteles, Moeller, Regina, Runde, Volker, Sandmann, Matthias, Hautzel, Hubertus, Wilop, Stefan, Krohn, Thomas, Dürk, Heinz, Strumberg, Dirk, Heike, Michael, Ose, Claudia, Brinkmann, Marcus, Trenn, Guido, Kloke, Otto, Kreisel-Büstgens, Christiane, Dang, Tu-Anh, Heil, Gerhard, Jöckel, Karl-Heinz, Hoelzer, Dieter, Klapper, Wolfram, Duehrsen, Ulrich
Published in Blood (02.12.2016)

Get full text

Journal Article

Management of peripheral arterial disease in a patient with myelodysplastic syndrome and severe thrombocytopenia

Management of peripheral arterial disease in a patient with myelodysplastic syndrome and severe thrombocytopenia

by Stavroulakis, Konstantinos, Mazaris, Savvas, Donas, Konstantinos, Sensebat, Özgün, Karaindros, Konstantinos, Kloke, Otto, Matkares, Joseph, Brinkmann, Jan F
Published in VASA (01.07.2013)

Get more information

Journal Article

Prolonged Administration of Interferon-α in Patients With Chronic-Phase Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Before Allogeneic Bone Marrow Transplantation May Adversely Affect Transplant Outcome

Prolonged Administration of Interferon-α in Patients With Chronic-Phase Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Before Allogeneic Bone Marrow Transplantation May Adversely Affect Transplant Outcome

by Beelen, Dietrich W., Graeven, Ullrich, Elmaagacli, Ahmet H., Niederle, Norbert, Kloke, Otto, Opalka, Bertram, Schaefer, Ulrich W.
Published in Blood (15.05.1995)

Get full text

Journal Article

Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon α-2b alone or in combination with interferon γ

Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon α-2b alone or in combination with interferon γ

by OPALKA, B, WANDL, U. B, BECHER, R, KLOBE, O, NAGEL-HIEMKE, M, MORITZ, T, BEER, U, SEEBER, S, NIEDERLE, N
Published in Blood (01.11.1991)

Get full text

Journal Article

Rapamycin antagonizes interleukin-6 mediated growth arrest and differentiation of myeloblastic M1 cells

Rapamycin antagonizes interleukin-6 mediated growth arrest and differentiation of myeloblastic M1 cells

by Kloke, Otto, Kummer, Gerhard, Seeber, Siegfried
Published in Immunology letters (01.11.1997)

Get full text

Journal Article

Development and mechanisms of interferon resistance

Development and mechanisms of interferon resistance

by Kloke, Otto, Niederle, Norbert
Published in Cancer treatment reviews (01.12.1990)

Get full text

Journal Article Conference Proceeding

Long-term treatment of chronic myelogenous leukemia with different interferons: results from three studies

Long-term treatment of chronic myelogenous leukemia with different interferons: results from three studies

by Niederle, N, Kloke, O, Wandl, U B, Becher, R, Moritz, T, Opalka, B
Published in Leukemia & lymphoma (01.01.1993)

Get more information

Journal Article

Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia

Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia

by Wandl, U B, Kloke, O, Nagel-Hiemke, M, Moritz, T, Becher, R, Opalka, B, Holtkamp, W, Bartels, H, Seeber, S, Niederle, N
Published in British journal of haematology (01.08.1992)

Get more information

Journal Article

Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatment

Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatment

by Wandl, U B, Bützler, R, Niederle, N, Kloke, O, Mengelkoch, B, Becher, R, Seeber, S, Opalka, B
Published in Leukemia (01.05.1994)

Get more information

Journal Article

Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot study

Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot study

by Thiele, J, Kvasnicka, H M, Niederle, N, Kloke, O, Schmidt, M, Lienhard, H, Zirbes, T, Meuter, R B, Leder, L D, Fischer, R
Published in American journal of hematology (01.09.1995)

Get more information

Journal Article

Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapy

Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapy

by Opalka, B, Wandl, U, Beer, U, Roggenbuck, U, Kloke, O, Niederle, N
Published in Leukemia (01.06.1991)

Get more information

Journal Article

Interferon alfa-2b in the treatment of chronic myelogenous leukemia

Interferon alfa-2b in the treatment of chronic myelogenous leukemia

by Niederle, N, Kloke, O, Osieka, R, Wandl, U, Opalka, B, Schmidt, C G
Published in Seminars in oncology (01.06.1987)

Get more information

Journal Article

Formation of the Early‐Region‐2 Transcription‐Factor‐1‐Retinoblastoma‐Protein (E2F‐1‐RB) Trans Repressor and Release of the Retinoblastoma Protein from Nuclear Complexes Containing Cyclin A is Induced by Interferon α in U937V Cells but not in Interferon‐α‐Resistant U937VR Cells

Formation of the Early‐Region‐2 Transcription‐Factor‐1‐Retinoblastoma‐Protein (E2F‐1‐RB) Trans Repressor and Release of the Retinoblastoma Protein from Nuclear Complexes Containing Cyclin A is Induced by Interferon α in U937V Cells but not in Interferon‐α‐Resistant U937VR Cells

by Kirch, Hans‐Christoph, Putzer, Brigitte, Brockmann, Dieter, Esche, Helmut, Kloke, Otto
Published in European journal of biochemistry (01.06.1997)

Get full text

Journal Article

Minimal Residual Disease in Patients With Chronic Myelogenous Leukemia Undergoing Long-term Treatment With Recombinant Interferon a-2b Alone or in Combination With Interferon γ

Minimal Residual Disease in Patients With Chronic Myelogenous Leukemia Undergoing Long-term Treatment With Recombinant Interferon a-2b Alone or in Combination With Interferon γ

by Opalka, Bertram, Wandl, Ursula Brigitte, Becher, Reinhard, Kloke, Otto, Nagel-Hiemke, Marianne, Moritz, Thomas, Beer, Ulrike, Seeber, Siegfried, Niederle, Norbert
Published in Blood (01.11.1991)

Get full text

Journal Article

Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell lines

Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell lines

by Siebert, Reiner, Willers, Christoph P., Fosså, Alexander, Kloke, Otto, Nowrousian, Mohammad R., Seeber, Siegfried, Opalka, Bertram
Published in Leukemia research (01.02.1996)

Get full text

Journal Article

Modulation of the antigraft response by preimmunization. Lack of correlation between regulatory events and graft survival

Modulation of the antigraft response by preimmunization. Lack of correlation between regulatory events and graft survival

by Kloke, O, Kölsch, E
Published in Transplantation (01.11.1984)

Get more information

Journal Article

Formation of the Early‐Region‐2 Transcription‐Factor‐1‐Retinoblastoma‐Protein (E2F‐1‐RB) TransRepressor and Release of the Retinoblastoma Protein from Nuclear Complexes Containing Cyclin A is Induced by Interferon α in U937V Cells but not in Interferon‐α‐Resistant U937VR Cells

Formation of the Early‐Region‐2 Transcription‐Factor‐1‐Retinoblastoma‐Protein (E2F‐1‐RB) TransRepressor and Release of the Retinoblastoma Protein from Nuclear Complexes Containing Cyclin A is Induced by Interferon α in U937V Cells but not in Interferon‐α‐Resistant U937VR Cells

by Kirch, Hans‐Christoph, Putzer, Brigitte, Brockmann, Dieter, Esche, Helmut, Kloke, Otto
Published in European journal of biochemistry (15.06.1997)

Get full text

Journal Article

Treatment of chronic myelogenous leukemia with different cytokines

Treatment of chronic myelogenous leukemia with different cytokines

by Wandl, U B, Opalka, B, Kloke, O, Nagel-Hiemke, M, Moritz, T, Niederle, N
Published in Seminars in oncology (01.04.1992)

Get more information

Journal Article

A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma

A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma

by LINDEMANN, A, HÖFFKEN, K, FRANKS, C. R, HERRMANN, F, MERTELSMANN, R. H, SCHMIDT, R. E, DIEHL, V, KLOKE, O, GAMM, H, HAYUNGS, J, OSTER, W, BÖHM, M, KOLITZ, J. E
Published in Cancer Immunology Immunotherapy (01.04.1989)

Get full text

Journal Article

Tumor necrosis factor α modifies resistance to interferon α in vivo : first clinical data

Tumor necrosis factor α modifies resistance to interferon α in vivo : first clinical data

by MORITZ, T, KLOKE, O, NAGEL-HIEMKE, M, KUMMER, G, WANDL, U. B, OPALKA, B, PLAPPERT, B, KEMPENI, J, SEEBER, S, NIEDERLE, N
Published in Cancer Immunology Immunotherapy (01.09.1992)

Get full text

Journal Article